Humira had 2019 sales of $14.9 billion. Autoimmune
Post# of 145445
Ohm20's list suggests a significantly expanded market for Leronlimab beyond cancer and beyond the current indications for existing biologics (Alzheimers, Parkinson's, ALS).
There are many ways to get to $100B.
The sky is the limit. How high is the sky?
Check back in 10 years.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)